Skip to main content
Article thumbnail
Location of Repository

The Importance of Brain Banks for Molecular Neuropathological Research: The New South Wales Tissue Resource Centre Experience

By Irina Dedova, Antony Harding, Donna Sheedy, Therese Garrick, Nina Sundqvist, Clare Hunt, Juliette Gillies and Clive G. Harper


New developments in molecular neuropathology have evoked increased demands for postmortem human brain tissue. The New South Wales Tissue Resource Centre (TRC) at The University of Sydney has grown from a small tissue collection into one of the leading international brain banking facilities, which operates with best practice and quality control protocols. The focus of this tissue collection is on schizophrenia and allied disorders, alcohol use disorders and controls. This review highlights changes in TRC operational procedures dictated by modern neuroscience, and provides examples of applications of modern molecular techniques to study the neuropathogenesis of many different brain disorders

Topics: Review
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2008). A comparison of the lengths of androgen receptor triplet repeats in brain and blood in motor neuron diseases.
    2. (2006). A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia.
    3. A proteome analysis of the dorsolateral prefrontal cortex in human alcoholic patients.
    4. (2008). A simple method for comparing microarray genotype data between brain and other tissues.
    5. Abnormal pathways on the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study.
    6. (2005). Alcohol-responsive genes in the frontal cortex and nucleus accumbens of human alcoholics.
    7. (2007). Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.
    8. (2007). Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia.
    9. (2006). Altered gene expression in the amygdala in schizophrenia: up-regulation of genes located in the cytomatrix active zone.
    10. (2008). Altered gene expression in the superior temporal gyrus in schizophrenia.
    11. (2007). Altered gene expression profiles in the frontal cortex of cirrhotic alcoholics.
    12. Altered proteins of the anterior cingulate cortex white matter proteome in schizophrenia.
    13. (2008). An Australian Brain Bank: A critical investment with a high return. Cell Tissue Bank
    14. An epigenetic analysis of SOD1
    15. (2001). Application of DNA microarrays to study human alcoholism.
    16. (2006). Are metallothionein genes silenced in ALS?
    17. (2008). Assessing RNA quality in postmortem human brain tissue.
    18. (1994). Association. Diagnostic and Statistical Manual of Mental Disorders, 4 th Ed.; American Psychiatric Association:
    19. (2007). Brain bank of the Brazilian aging brain study group - a milestone reached and more than 1,600 collected brains. Cell Tissue Bank
    20. (2009). Brain banking: Opportunities, challenges and meaning for the future.
    21. (2006). Chronic smoking and alcoholism change expression of selective genes in the human prefrontal cortex.
    22. Comparative gene expression in brain regions of human alcoholics.
    23. (2006). Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia.
    24. (2002). Decreased [ 3H] spiperone binding in the anterior cingulate cortex of schizophrenia patients: An autoradiographic study. Neuroscience
    25. (2005). Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia.
    26. (2005). Diagnostic Instrument for Brain Studies- Revised; Mental Health Research Institute:
    27. (2008). Differential protein expression in the corpus callosum (Genu) of human alcoholics.
    28. (2007). Differential protein expression in the corpus callosum (splenium) of human alcoholics: A proteomics study.
    29. (2006). Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study.
    30. (2007). Differential protein expression profiles in the hippocampus of human alcoholics.
    31. (2008). Dysregulation of cell death machinery in the prefrontal cortex of human alcoholics.
    32. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.
    33. (2004). Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human
    34. (2008). Elevated Synaptophysin I in the Prefrontal Cortex of Human Chronic Alcoholics. Synapse
    35. (2006). Evidence for specific phases in the development of human neuromelanin.
    36. (2003). Expression of hNP22 is altered in the frontal cortex and hippocampus of the alcoholic human brain.
    37. (2005). Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia.
    38. (2006). Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.
    39. (2005). Flaviviruses in motor neuron disease.
    40. (2000). Gene expression in human alcoholism: microarray analysis of frontal cortex.
    41. (2004). Gene expression profiling of individual cases reveals consistent transcriptional changes in alcoholic human
    42. (2004). Genetic study of alcoholism and novel gene expression in the alcoholic brain. Addict Biol.
    43. (2007). How a neuropsychiatric brain bank should be run: A consensus paper of Brainnet Europe
    44. (2003). How important are brain banks for alcohol research?
    45. (2006). Human postmortem tissue: what quality markers matter?
    46. (2009). Immunohistochemical localisation of the NK1 receptor in the human amygdala: preliminary
    47. (2006). Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia.
    48. (2006). Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia.
    49. (2001). Increased tachykinin NK(1) receptor immunoreactivity in the prefrontal cortex in schizophrenia.
    50. (2004). Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology
    51. (2005). Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients. Neuroreport
    52. (2008). Is brain banking of psychiatric cases valuable for neurobiological research? Clinics
    53. (2000). Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex.
    54. (2007). Localised reductions in gyrification in the posterior cingulate: Schizophrenia and controls.
    55. (2004). M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia. Neuropsychopharmacology
    56. (2005). M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood
    57. (2009). Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol.
    58. (2003). Methods for the identification of differentially expressed genes in human post-mortem brain. Methods
    59. (2008). Monocyte Chemoattractant Protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's
    60. (2007). Neuroadaptions in Human Chronic Alcoholics: Dysregulation of the NF-KB System. PLoS ONE
    61. (1998). Neurofibrillary degeneration and cell loss in the nucleus basalis n comparison to cortical Alzheimer pathology.
    62. Neurogenomics: At the intersection of neurobiology and genome sciences.
    63. (2004). Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia.
    64. (2003). Neuropathological alterations in alcoholic brains. Studies arising from the New South Wales Tissue Resource Centre.
    65. (2006). No differences in calcium-binding protein immunoreactivity in the posterior cingulate and visual cortex: schizophrenia and controls.
    66. (2004). Organization. Disease incidence, prevalence and disability. In World Health Organisation- Global Burden of Disease -
    67. (2002). Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics.
    68. (2006). Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals. Neuropsychopharmacology
    69. (1997). Perivascular astrocytes within Alzheimer's disease plaques. Neuroreport
    70. (2006). Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, D-amino acid oxidase (DAAO) and kyurenine aminotransferase-1 (KAT-1).
    71. Proteome analysis of the dorsolateral prefrontal region from healthy individuals.
    72. (2008). Reliability of post-mortem psychiatric diagnosis for neuroscience research.
    73. (2002). Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia. Neuropsychopharmacology
    74. (2004). Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.
    75. (2008). Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human
    76. (2000). Tachykinin NK1 and NK3 receptors in the prefrontal cortex of the human brain.
    77. (2007). Tau isoform expression in frontotemporal dementia without tau deposition.
    78. (2008). TDP-43 inclusions do not protect motor neurons from sporadic ALS.
    79. (2004). The application of proteomics to the human alcoholic
    80. The cerebral cortex is damaged in chronic alcoholics.
    81. (2008). The collection and processing of human brain tissue for research. Cell Tissue Bank
    82. (2006). The diagnosis is critical for psychiatric brain banks: An interrater reliability study.
    83. (1995). The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins.
    84. (2006). Tissue preparation and banking.
    85. (2008). Transketolase: Observations in alcohol-related brain damage research.
    86. (2008). Twenty-first century brain banking. Processing brains for research: The Columbia University methods. Acta Neuropathol.
    87. (2007). Validation of endogenous controls for quantitative gene expression analysis: application on brain cortices of human chronic alcoholics.
    88. (2002). Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.